Authors: | Mato, A. R.; Pagel, J. M.; Coombs, C. C.; Shah, N. N.; Lamanna, N.; Munir, T.; Lech-Maranda, E.; Eyre, T. A.; Woyach, J. A.; Wierda, W. G.; Cheah, C. Y.; Cohen, J. B.; Roeker, L. E.; Patel, M. R.; Fakhri, B.; Barve, M. A.; Tam, C. S.; Lewis, D. J.; Gerson, J. N.; Alencar, A. J.; Ujjani, C. S.; Flinn, I. W.; Sundaram, S.; Ma, S.; Jagadeesh, D.; Rhodes, J. M.; Taylor, J.; Abdel-Wahab, O.; Ghia, P.; Schuster, S. J.; Wang, D.; Nair, B.; Zhu, E.; Tsai, D.; Davids, M. S.; Brown, J. R.; Jurczak, W. |
Abstract Title: | Pirtobrutinib, a next generation, highly selective, non-covalent BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study |
Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 138 |
Issue: | Suppl. 1 |
Meeting Dates: | 2021 Dec 11-14 |
Meeting Location: | Atlanta, GA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2021-11-23 |
Language: | English |
ACCESSION: | WOS:000736398801165 |
DOI: | 10.1182/blood-2021-147599 |
PROVIDER: | wos |
Notes: | Meeting Abstract: 391 -- Hybrid meeting, also took place online -- Source: Wos |